REVIEW OF COVID-19 VACCINE ORDERED
The AstraZeneca vaccine is under urgent review by the federal government after Europe listed blood clots as a very rare side effect.
The review comes after a small number ofpeople experienced a rare blood clotting condition after vaccination.
The condition appears in around 1 in 200,000 people, according to Chief Medical Officer Professor Paul Kelly.
Professor Kelly stressed that the AstraZeneca vaccine was “very effective and extremely safe for most people.”